Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antibiotic combination
|
| gptkbp:ATCCode |
gptkb:J01DI
|
| gptkbp:CASNumber |
2446185-73-6
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developer |
gptkb:Venatorx_Pharmaceuticals
|
| gptkbp:hasComponent |
gptkb:cefepime
gptkb:taniborbactam |
| https://www.w3.org/2000/01/rdf-schema#label |
cefepime-taniborbactam
|
| gptkbp:intendedUse |
treatment of complicated urinary tract infections
|
| gptkbp:mechanismOfAction |
beta-lactam antibiotic and beta-lactamase inhibitor
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:spectrumOfActivity |
Gram-negative bacteria
carbapenem-resistant Enterobacterales |
| gptkbp:status |
investigational
|
| gptkbp:bfsParent |
gptkb:Venatorx_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|